GlassScriptPhysician profile
Ashley Danielle Thomas
NPI 1265033625
$1,935.83
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,238 · 2022: $698.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $426.87 | 2021-2022 | |
| Abbvie INC. | $408.75 | 2021 | |
| Insmed, INC. | $270.38 | 2021-2022 | |
| Gilead Sciences, INC. | $180.43 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $119.74 | 2021-2022 | |
| Viiv Healthcare Company | $113.61 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $112.85 | 2021-2022 | |
| La Jolla Pharmaceutical Company | $92.73 | 2021-2022 | |
| Cumberland Pharmaceuticals, INC. | $76.16 | 2022 | |
| Pfizer INC. | $36.18 | 2022 | |
| Grifols USA, LLC | $35.96 | 2022 | |
| Ambu INC. | $29.07 | 2021 | |
| Melinta Therapeutics, LLC | $21.22 | 2022 | |
| Mayne Pharma Commercial LLC | $11.88 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.